ORIJOINT "DIACEREIN 50mg. IP + GLUCOSAMINE 750mg. IP + METHYL SULPHONYL METHANE 250mg. IP

Orijoint tablets are a joint-care medicine used for the pain and stiffness of knee osteoarthritis. Main uses: relief of pain and stiffness in osteoarthritis of the knee; reduction of joint inflammation, swelling and tenderness; improvement of joint movement and daily function in knee osteoarthritis; support of cartilage health in worn knee joints.

Common side effects of Orijoint Tablet include diarrhoea or loose motions; abdominal pain or cramps; nausea, heartburn or gas; yellowish-brown discolouration of urine (usually harmless); headache; skin rash or itching. Get medical help at once if you notice severe or persistent diarrhoea with fluid loss; yellowing of the skin or eyes, dark urine or pain in the upper abdomen (liver reaction); serious allergic reaction with swelling of the face, lips or tongue and breathing difficulty.

Each Orijoint tablet contains Diacerein 50 mg + Glucosamine 750 mg + Methyl Sulphonyl Methane 250 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Orijoint Tablet only as your doctor advises.

The MRP of Orijoint Tablet is ₹216 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹164.57 and the PTS is ₹148.11.

Each Orijoint tablet contains Diacerein 50 mg + Glucosamine 750 mg + Methyl Sulphonyl Methane 250 mg. It comes in a pack of 10x10 (Alu Alu).

Inside the knee, diacerein lowers the substances that drive inflammation, so swelling, pain and stiffness ease. Glucosamine acts as a building material for the cartilage and the joint fluid that cushion the joint surfaces. Methyl Sulphonyl Methane supplies sulphur that joint tissue needs and helps with joint comfort and flexibility during daily activity.

Must not be used by anyone allergic to diacerein, glucosamine, methyl sulphonyl methane or any other ingredient of the tablet. Must not be used in severe kidney disease. Must not be used in patients with current or previous liver disease. Must not be used in children and adolescents below 18 years of age. Must not be used during pregnancy and breastfeeding, or in patients with inflammatory bowel disease, intestinal obstruction, unexplained rectal bleeding or a history of these problems.

Orijoint Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.